Cited 2 time in
Enhanced Redox Factor 1 (REF1)-modulated p53 Stabilization and JNK1 Dissociation in Response to Selenomethionine
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jung, Hwa Jin | - |
| dc.contributor.author | Kim, Hye Lim | - |
| dc.contributor.author | Seo, Young Rok | - |
| dc.date.accessioned | 2024-08-08T01:31:32Z | - |
| dc.date.available | 2024-08-08T01:31:32Z | - |
| dc.date.issued | 2013-09 | - |
| dc.identifier.issn | 0250-7005 | - |
| dc.identifier.issn | 1791-7530 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/15381 | - |
| dc.description.abstract | Aim: p53 is reportedly activated without any genotoxicity through redox modulation of redox factor 1 (REF1). REF1 is documented to modulate the redox status under selenomethionine (SeMet). In this study, we investigated the mechanism of p53 stabilization by SeMet. Materials and Methods: We mainly used ubiquitination assay and immunoprecipitation to determine the potential role of REF1 and c-jun N-terminal kinase 1 (JNK) in modulation of p53 stabilization by SeMet. Results: The amount of ubiquitinated p53 decreased significantly under SeMet treatment, suggesting that SeMet might inhibit the proteasome-dependent degradation of p53. In addition, we observed that JNK was considerably associated with p53 in REF1 siRNA-treated cells, implying a possible role for SeMet-induced REF1 activity in modulation of the interaction between JNK and p53 via changes in p53 redox status. Conclusion: Our results suggest that the alternate mechanism of p53 stabilization by SeMet might provide an important clue in elucidating the molecular mechanism of chemopreventative compounds against various oxidative stresses. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | INT INST ANTICANCER RESEARCH | - |
| dc.title | Enhanced Redox Factor 1 (REF1)-modulated p53 Stabilization and JNK1 Dissociation in Response to Selenomethionine | - |
| dc.type | Article | - |
| dc.publisher.location | 그리이스 | - |
| dc.identifier.scopusid | 2-s2.0-84885004141 | - |
| dc.identifier.wosid | 000327055200014 | - |
| dc.identifier.bibliographicCitation | ANTICANCER RESEARCH, v.33, no.9, pp 3645 - 3651 | - |
| dc.citation.title | ANTICANCER RESEARCH | - |
| dc.citation.volume | 33 | - |
| dc.citation.number | 9 | - |
| dc.citation.startPage | 3645 | - |
| dc.citation.endPage | 3651 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | PREVENTION TRIAL SELECT | - |
| dc.subject.keywordPlus | DNA-REPAIR | - |
| dc.subject.keywordPlus | PROSTATE-CANCER | - |
| dc.subject.keywordPlus | VITAMIN-E | - |
| dc.subject.keywordPlus | SELENIUM | - |
| dc.subject.keywordPlus | PROTEIN | - |
| dc.subject.keywordPlus | REF-1 | - |
| dc.subject.keywordPlus | DEGRADATION | - |
| dc.subject.keywordPlus | DAMAGE | - |
| dc.subject.keywordPlus | CELLS | - |
| dc.subject.keywordAuthor | JNK | - |
| dc.subject.keywordAuthor | p53 | - |
| dc.subject.keywordAuthor | redox factor 1 | - |
| dc.subject.keywordAuthor | selenomethionine | - |
| dc.subject.keywordAuthor | ubiquitination | - |
| dc.subject.keywordAuthor | cancer prevention | - |
| dc.subject.keywordAuthor | protein stability | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
